Scinai Immunotherapeutics
Quarterly Financials
| Values in thousands | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|
Revenue | $582 | $206 | $168 |
Gross Profit | -167 | -167 | -249 |
EBITDA | -1,193 | 10,986 | |
EBIT | -2,166 | 10,488 | |
Net Income | -1,549 | -2,230 | 10,455 |
Net Change In Cash | 582 | 206 | 168 |
Free Cash Flow | -1,076 | -2,042 | |
Cash | 1,964 | 1,032 | |
Basic Shares | 806 | 3,411,983 | 843 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $658 | $0 | $0 | $0 |
Gross Profit | -580 | -512 | 0 | |
EBITDA | 7,867 | -9,192 | -10,499 | -10,391 |
EBIT | 6,218 | -9,706 | -11,061 | -10,862 |
Net Income | 4,796 | -6,500 | -5,796 | -8,206 |
Net Change In Cash | 658 | 0 | 0 | 0 |
Free Cash Flow | -6,347 | -10,019 | -8,101 | -7,565 |
Cash | 1,964 | 4,870 | 14,075 | 17,374 |
Basic Shares | 806 | 390 | 188 | 141 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | -$2.60 |
2025-03-31 | $4.31 |
2024-12-31 | -$2.63 |
2024-09-30 | $12.39 |
